{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:39:01Z","timestamp":1793047141784,"version":"4.5.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.idc.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:47:16Z","timestamp":1785358036000},"page":"793-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Skin and Soft Tissue Infections in Persons Who Use Drugs"],"prefix":"10.1016","volume":"40","author":[{"given":"Sophia K.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha","family":"Appa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/cid\/ciac543","article-title":"Estimated number of people who inject drugs in the United States","volume":"76","author":"Bradley","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jama.2025.20347","article-title":"Trends in injecting methamphetamine and opioids among people who inject drugs in the US","volume":"335","author":"D\u2019Adamo","year":"2026","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.idc.2026.06.002_bib4","first-page":"376","article-title":"Estimated number of people who inject drugs in the United States, 2022","volume":"116","author":"Bradley","year":"2026","journal-title":"Am J Publ Health"},{"issue":"7","key":"10.1016\/j.idc.2026.06.002_bib5","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1093\/cid\/ciaa008","article-title":"Bacterial infections associated with substance use disorders, large cohort of United States Hospitals, 2012-2017","volume":"71","author":"McCarthy","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"Suppl 5","key":"10.1016\/j.idc.2026.06.002_bib6","doi-asserted-by":"crossref","first-page":"S429","DOI":"10.1093\/infdis\/jiaa149","article-title":"National public health burden estimates of endocarditis and skin and soft-tissue infections related to injection drug use: a review","volume":"222","author":"See","year":"2020","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2026.06.002_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf108","article-title":"Prevalence of injection-related bacterial and fungal infection among people who inject drugs: a systematic review and meta-analysis","volume":"12","author":"Wheeler","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2026.06.002_bib8","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/hsc.13559","article-title":"A community-based study of abscess self-treatment and barriers to medical care among people who inject drugs in the United States","volume":"30","author":"Ozga","year":"2022","journal-title":"Health Soc Care Community"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12954-024-00939-6","article-title":"Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder","volume":"21","author":"Marks","year":"2024","journal-title":"Harm Reduct J"},{"issue":"11","key":"10.1016\/j.idc.2026.06.002_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206893","article-title":"Age-based health and economic burden of skin and soft tissue infections in the United States, 2000 and 2012","volume":"13","author":"Tun","year":"2018","journal-title":"PLoS One"},{"issue":"Suppl 5","key":"10.1016\/j.idc.2026.06.002_bib11","doi-asserted-by":"crossref","first-page":"S451","DOI":"10.1093\/infdis\/jiaa012","article-title":"Trends in morbidity, mortality, and cost of hospitalizations associated with infectious disease sequelae of the opioid epidemic","volume":"222","author":"Coyle","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2026.06.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108057","article-title":"Incidence and treatment costs of severe bacterial infections among people who inject heroin: a cohort study in South London, England","volume":"212","author":"Lewer","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.idc.2026.06.002_bib13","doi-asserted-by":"crossref","first-page":"e659","DOI":"10.1016\/S2214-109X(23)00057-8","article-title":"Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review","volume":"11","author":"Degenhardt","year":"2023","journal-title":"Lancet Global Health"},{"issue":"4","key":"10.1016\/j.idc.2026.06.002_bib14","doi-asserted-by":"crossref","first-page":"ofaf165","DOI":"10.1093\/ofid\/ofaf165","article-title":"Cutaneous abscess prevalence and risk factors among people who inject drugs in Denver, Colorado","volume":"12","author":"Olson","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2026.06.002_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196944","article-title":"Both localized and systemic bacterial infections are predicted by injection drug use: a prospective follow-up study in Swedish criminal justice clients","volume":"13","author":"Dahlman","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.idc.2026.06.002_bib16","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/00952991003592311","article-title":"Risk practices associated with bacterial infections among injection drug users in Denver, Colorado","volume":"36","author":"Phillips","year":"2010","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.idc.2026.06.002_bib17","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.drugpo.2016.08.006","article-title":"Injection-site vein loss and soft tissue abscesses associated with black tar heroin injection: a cross-sectional study of two distinct populations in USA","volume":"39","author":"Summers","year":"2017","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.idc.2026.06.002_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.112886","article-title":"Trends of all opioid-heroin-and fentanyl-involved nonfatal overdoses in the United States, October 2020 - april 2025","volume":"276","author":"Liu","year":"2025","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.idc.2026.06.002_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2024.111419","article-title":"Decrease in injection and rise in smoking and snorting of heroin and synthetic opioids, 2000-2021","volume":"263","author":"Karandinos","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.idc.2026.06.002_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.55882","article-title":"Prevalence of illicit drug detection in 5 US cities among out-of-treatment people who inject drugs","volume":"9","author":"El-Bassel","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.idc.2026.06.002_bib21","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/dar.14093","article-title":"Fentanyl polysubstance use patterns and their associations with hepatitis C virus, skin and soft tissue infections, and non-fatal overdose among people who inject drugs in New York City","volume":"44","author":"Khezri","year":"2025","journal-title":"Drug Alcohol Rev"},{"key":"10.1016\/j.idc.2026.06.002_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115417","article-title":"Immunosuppression by opioids: mechanisms of action on innate and adaptive immunity","volume":"209","author":"Sun","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"5152","key":"10.1016\/j.idc.2026.06.002_bib23","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.15585\/mmwr.mm675152a3","article-title":"Wound botulism outbreak among persons who use black tar heroin - san Diego County, California, 2017-2018","volume":"67","author":"Peak","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.idc.2026.06.002_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.anaerobe.2014.09.005","article-title":"View from the front lines: an emergency medicine perspective on clostridial infections in injection drug users","volume":"30","author":"Gonzales y Tucker","year":"2014","journal-title":"Anaerobe"},{"issue":"6","key":"10.1016\/j.idc.2026.06.002_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01622-15","article-title":"Methamphetamine alters the antimicrobial efficacy of phagocytic cells during methicillin-resistant Staphylococcus aureus skin infection","volume":"6","author":"Mihu","year":"2015","journal-title":"mBio"},{"issue":"11","key":"10.1016\/j.idc.2026.06.002_bib26","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.3201\/eid1311.070148","article-title":"Methamphetamine use and methicillin-resistant Staphylococcus aureus skin infections","volume":"13","author":"Cohen","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2026.06.002_bib27","first-page":"445","article-title":"Impact of methamphetamine on infection and immunity","volume":"8","author":"Salamanca","year":"2014","journal-title":"Front Neurosci"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/320879","article-title":"Risk factors for skin and soft-tissue abscesses among injection drug users: a case-control study","volume":"33","author":"Murphy","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"18","key":"10.1016\/j.idc.2026.06.002_bib29","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMra042823","article-title":"Bacterial infections in drug users","volume":"353","author":"Gordon","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12954-020-00447-3","article-title":"Predictors of skin and soft tissue infections among sample of rural residents who inject drugs","volume":"17","author":"Baltes","year":"2020","journal-title":"Harm Reduct J"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1080\/08897077.2016.1263592","article-title":"Behavioral characteristics and injection practices associated with skin and soft tissue infections among people who inject drugs: a community-based observational study","volume":"38","author":"Dahlman","year":"2017","journal-title":"Subst Abuse"},{"key":"10.1016\/j.idc.2026.06.002_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103198","article-title":"Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs","volume":"94","author":"Jawa","year":"2021","journal-title":"Int J Drug Policy"},{"issue":"3","key":"10.1016\/j.idc.2026.06.002_bib33","first-page":"495","article-title":"Soft tissue, bone, and joint infections in people who inject drugs","volume":"34","author":"Saldana","year":"2020","journal-title":"Infect Dis Clin"},{"key":"10.1016\/j.idc.2026.06.002_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104485","article-title":"Water, sanitation and hygiene insecurity predict abscess incidence among people who inject drugs in a binational US-Mexico metropolitan area: a longitudinal cohort study","volume":"129","author":"Calder\u00f3n-Villarreal","year":"2024","journal-title":"Int J Drug Policy"},{"issue":"7","key":"10.1016\/j.idc.2026.06.002_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235350","article-title":"Prevalence and severity of abscesses and cellulitis, and their associations with other health outcomes, in a community-based study of people who inject drugs in London, UK","volume":"15","author":"Wright","year":"2020","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.idc.2026.06.002_bib36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/ADM.0000000000000844","article-title":"Under the skin: the relationship between subcutaneous injection and skin infections among people who inject drugs","volume":"16","author":"Freibott","year":"2022","journal-title":"J Addiction Med"},{"key":"10.1016\/j.idc.2026.06.002_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.111053","article-title":"Health risks associated with smoking versus injecting fentanyl among people who use drugs in California","volume":"255","author":"Megerian","year":"2024","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"10.1016\/j.idc.2026.06.002_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.15585\/mmwr.mm7306a2","article-title":"Routes of drug use among drug overdose deaths - united States, 2020-2022","volume":"73","author":"Tanz","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.idc.2026.06.002_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0303403","article-title":"Innovation and adaptation: the rise of a fentanyl smoking culture in San Francisco","volume":"19","author":"Ciccarone","year":"2024","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.idc.2026.06.002_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s40257-023-00835-y","article-title":"Mucocutaneous manifestations of recreational drug use","volume":"25","author":"Alexander-Savino","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.idc.2026.06.002_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104218","article-title":"Effect of incarceration and opioid agonist treatment transitions on risk of hospitalisation with injection drug use-associated bacterial infections: a self-controlled case series in New South Wales, Australia","volume":"122","author":"Brothers","year":"2023","journal-title":"Int J Drug Policy"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-63574-y","article-title":"Staphylococcus aureus carriage and prevalence of skin and soft tissue infections among people who inject drugs: a longitudinal study","volume":"14","author":"J\u00f6rgensen","year":"2024","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0376-8716(00)00161-7","article-title":"Physical injecting sites among injecting drug users in Sydney, Australia","volume":"62","author":"Darke","year":"2001","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"10.1016\/j.idc.2026.06.002_bib44","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/cid\/ciu444","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America","volume":"59","author":"Stevens","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2026.06.002_bib45","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/acem.12727","article-title":"Microbiology and initial antibiotic therapy for injection drug users and non-injection drug users with cutaneous abscesses in the era of community-associated methicillin-resistant Staphylococcus aureus","volume":"22","author":"Jenkins","year":"2015","journal-title":"Acad Emerg Med"},{"issue":"26","key":"10.1016\/j.idc.2026.06.002_bib46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.15585\/mmwr.mm6826a2","article-title":"Bacterial and fungal infections in persons who inject drugs - western New York, 2017","volume":"68","author":"Hartnett","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib47","first-page":"187","article-title":"Infectious complications of injection drug use","volume":"106","author":"Marks","year":"2022","journal-title":"Med Clin"},{"issue":"26","key":"10.1016\/j.idc.2026.06.002_bib48","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1607033","article-title":"A placebo-controlled trial of antibiotics for smaller skin abscesses","volume":"376","author":"Daum","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.idc.2026.06.002_bib49","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1507476","article-title":"Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess","volume":"374","author":"Talan","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.idc.2026.06.002_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020991","article-title":"Antibiotics for uncomplicated skin abscesses: systematic review and network meta-analysis","volume":"8","author":"Wang","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib51","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.annemergmed.2018.02.011","article-title":"Systemic antibiotics for the treatment of skin and soft tissue abscesses: a systematic review and meta-analysis","volume":"73","author":"Gottlieb","year":"2019","journal-title":"Ann Emerg Med"},{"issue":"23","key":"10.1016\/j.idc.2026.06.002_bib52","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1056\/NEJMra1600673","article-title":"Necrotizing soft-tissue infections","volume":"377","author":"Stevens","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.idc.2026.06.002_bib53","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1086\/383471","article-title":"Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users","volume":"38","author":"Kimura","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3201\/eid1901.120044","article-title":"Infections with spore-forming bacteria in persons who inject drugs, 2000-2009","volume":"19","author":"Palmateer","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2026.06.002_bib56","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/cid\/cir005","article-title":"Recurrent wound botulism among injection drug users in California","volume":"52","author":"Yuan","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2026.06.002_bib57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/QCO.0000000000000902","article-title":"Community-acquired skin and soft-tissue infections in people who inject drugs","volume":"36","author":"Allaw","year":"2023","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.idc.2026.06.002_bib58","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.avsg.2021.06.018","article-title":"The needle and the damage done: a retrospective review of the health impact of recreational intravenous drug use and the collateral consequences for vascular surgery","volume":"78","author":"MacLeod","year":"2022","journal-title":"Ann Vasc Surg"},{"issue":"3","key":"10.1016\/j.idc.2026.06.002_bib59","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/dar.13389","article-title":"Prevalence and factors associated with chronic venous insufficiency, leg ulceration and deep-vein thrombosis among people who inject drugs in London, UK","volume":"41","author":"Doran","year":"2022","journal-title":"Drug Alcohol Rev"},{"issue":"8","key":"10.1016\/j.idc.2026.06.002_bib60","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf384","article-title":"Clinical microbiology in xylazine-associated wound infections","volume":"12","author":"Berg","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1186\/s12889-017-4210-2","article-title":"Effectiveness of needle and syringe programmes in people who inject drugs - an overview of systematic reviews","volume":"17","author":"Fernandes","year":"2017","journal-title":"BMC Public Health"},{"issue":"3","key":"10.1016\/j.idc.2026.06.002_bib62","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jsat.2012.01.003","article-title":"Skin and needle hygiene intervention for injection drug users: results from a randomized, controlled stage I pilot trial","volume":"43","author":"Phillips","year":"2012","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.idc.2026.06.002_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108646","article-title":"A randomized controlled trial of a brief behavioral intervention to reduce skin and soft tissue infections among people who inject drugs","volume":"221","author":"Phillips","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.idc.2026.06.002_bib64","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.55965","article-title":"Health, costs, and injection-related infections at a hypothetical overdose prevention center","volume":"9","author":"Padmanabhan","year":"2026","journal-title":"JAMA Netw Open"},{"issue":"11","key":"10.1016\/j.idc.2026.06.002_bib65","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/cid\/ciy924","article-title":"Addiction medicine consultations reduce readmission rates for patients with serious infections from opioid use disorder","volume":"68","author":"Marks","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2026.06.002_bib66","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/ADM.0000000000000725","article-title":"Medications for opioid use disorder associated with less against medical advice discharge among persons who inject drugs hospitalized with an invasive infection","volume":"15","author":"Nolan","year":"2021","journal-title":"J Addiction Med"},{"issue":"Suppl 5","key":"10.1016\/j.idc.2026.06.002_bib67","doi-asserted-by":"crossref","first-page":"S513","DOI":"10.1093\/infdis\/jiz516","article-title":"A comparison of medication for opioid use disorder treatment strategies for persons who inject drugs with invasive bacterial and fungal infections","volume":"222","author":"Marks","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2026.06.002_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108207","article-title":"Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infections","volume":"215","author":"Barocas","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"10.1016\/j.idc.2026.06.002_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004049","article-title":"Opioid agonist treatment and risk of death or rehospitalization following injection drug use-associated bacterial and fungal infections: a cohort study in New South Wales, Australia","volume":"19","author":"Brothers","year":"2022","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.idc.2026.06.002_bib70","doi-asserted-by":"crossref","first-page":"e650","DOI":"10.1093\/cid\/ciaa365","article-title":"Evaluation of partial oral antibiotic treatment for persons who inject drugs and are hospitalized with invasive infections","volume":"71","author":"Marks","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2026.06.002_bib71","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1093\/cid\/ciad144","article-title":"Opioid injection-associated bacterial infections in England, 2002-2021: a time series analysis of seasonal variation and the impact of coronavirus disease 2019","volume":"77","author":"Lewer","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2026.06.002_bib72","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaf257","article-title":"Incidence, patient-directed discharge, readmission, and mortality among people hospitalized with injecting-related infection: a population-based linkage study","volume":"12","author":"Masters","year":"2025","journal-title":"Open Forum Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2026.06.002_bib73","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/cid\/ciu778","article-title":"Single-dose oritavancin versus 7-10 days of vancomycin in the treatment of gram-positive acute bacterial skin and skin structure infections: the SOLO II noninferiority study","volume":"60","author":"Corey","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2026.06.002_bib74","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/cid\/civ982","article-title":"A randomized clinical trial of single-dose versus weekly dalbavancin for treatment of acute bacterial skin and skin structure infection","volume":"62","author":"Dunne","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"23","key":"10.1016\/j.idc.2026.06.002_bib75","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1310480","article-title":"Once-weekly dalbavancin versus daily conventional therapy for skin infection","volume":"370","author":"Boucher","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2026.06.002_bib76","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212559","article-title":"Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs","volume":"7","author":"Gonzalez","year":"2018","journal-title":"Drugs Context"},{"issue":"4","key":"10.1016\/j.idc.2026.06.002_bib77","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cmi.2017.08.028","article-title":"Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis","volume":"24","author":"Agarwal","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.idc.2026.06.002_bib78","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/QCO.0000000000001092","article-title":"The future approach for the management of acute bacterial skin and skin structure infections","volume":"38","author":"Tiseo","year":"2025","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2026.06.002_bib79","article-title":"Real-world use of dalbavancin in a United States tertiary referral center","volume":"17","author":"Polega","year":"2025","journal-title":"Cureus"},{"issue":"6","key":"10.1016\/j.idc.2026.06.002_bib80","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1007\/s15010-025-02585-x","article-title":"Experience of use of dalbavancin for the treatment of unlicensed indications in a UK tertiary infectious diseases setting","volume":"53","author":"Darlow","year":"2025","journal-title":"Infection"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552026000577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552026000577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:06:09Z","timestamp":1793045169000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552026000577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0891552026000577"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2026.06.002","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin and Soft Tissue Infections in Persons Who Use Drugs","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}